Baz, R. C., Shain, K. H., Hussein, M. A., Lee, J., Sullivan, D. M., FinleyOliver, E., . . . Alsina, M. (2014). Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma. Am J Hematol.
Citação norma ChicagoBaz, Rachid C., et al. "Phase II Study of Pegylated Liposomal Doxorubicin, Low-dose Dexamethasone, and Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma." Am J Hematol 2014.
MLA CitationBaz, Rachid C., et al. "Phase II Study of Pegylated Liposomal Doxorubicin, Low-dose Dexamethasone, and Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma." Am J Hematol 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.